The prognosis depends on the type of leukemia, the extent of the disease, age of the patient, and the general condition of the patient. Some patients can go into complete remission. The average five-year survival rate of leukemia is 60-65%.
The survival rate of acute lymphoblastic leukemia (ALL) depends on the age of the patient and the response to chemotherapy. The average five-year survival in ALL is 68.1%. Survival rates continue to improve with newer and improved treatment modalities. The prognosis is better in those under 35 years of age, and children have the best prognosis. The highest death rates due to ALL is seen in those over 65 years of age. 40% of adults can be cured of ALL. The average five-year survival rate of American children with ALL is around 85%. Children are considered cured of ALL if they are in remission (symptom-free period) for more than five years after treatment.
Around 98% of children with ALL achieve remission. Remission means a child doesn’t have any signs or symptoms of the condition, and blood cell counts are within normal limits.
Patients with leukemia may ultimately die due to multiple infections (bacterial, fungal, and viral), severe nutritional deficiencies, and failure of multiple organ systems. Patients can also face complications due to the treatment, which can sometimes be life-threatening.
What is leukemia?
Leukemia is a cancer of the blood cells and bone marrow. There is an abnormally high production of white bloodless (cells that fight infection and provide immunity), which are unable to mature properly leading to the symptoms in leukemia.
Based on the origin, they can be divided into two broad types, namely, myeloid and lymphoid:
- Myeloid leukemia (myelogenous leukemia) arises from the myeloid line of the white blood cells. Normal myeloid cells undergo differentiation to form leukocytes.
- Lymphoid leukemia (lymphoid or lymphoblastic leukemia) arises from the lymphoid line of cells in the bone marrow.
Based on how fast it progresses, it is divided into acute and chronic leukemia:
What are the types of leukemia?
Acute lymphocytic leukemia (ALL):
- It progresses rapidly and spreads to other organ systems through the blood.
- It mostly occurs in children and above the age of 45 years.
Acute myeloid leukemia (AML):
- It is the second most common leukemia in adults and rapidly progressive.
- It is commonly seen in adults aged over 55-60 years.
- The myeloid cells mutate, forming defective cells, and prevent the formation of normal, healthy blood cells (white, red, and platelets).
Chronic lymphocytic leukemia (CLL):
- It is slow-growing cancer that begins in the lymphocyte cells present in the bone marrow.
- There is abnormally high multiplication of the lymphocyte cells that are immature and do not function properly.
Chronic myeloid leukemia (CML):
- It is associated with a chromosomal abnormality known as the Philadelphia chromosome.
- The upper part of chromosome 22 breaks off and attaches to the lower part of chromosome 9. The upper part of chromosome 9 attaches to the lower part of chromosome 22.
Hairy cell leukemia (HCL):
- It is a rare subtype of CLL that progresses slowly.
- The bone marrow produces a high number of B-Cells, a type of white blood cell that fights against infection-causing a decrease in healthy blood cells.
Myelodysplastic syndromes (MDS):
A group of closely related diseases in which the bone marrow produces very few healthy, functioning red blood cells, white blood cells, platelets, or any combination of the three.
What are the signs and symptoms?
Some common signs and symptoms include:
How is leukemia treated?
Treatment involves one or a combination of the following treatment modalities:
- Chemotherapy: Single drug or a combination of different drugs to kill cancer cells.
- Radiation therapy: Radiation is used to damage, kill, and inhibit the growth of cancer cells.
- Bone marrow transplant: Diseased bone marrow is replaced with healthy bone marrow from the patient (autologous transplantation) or a donor (allologous transplantation).
- Immunotherapy: They modulate the body’s immune system attacking cancer cells.
- Treatment of pain, anemia, and infections
- Nutritional supplementation
- Palliative care in untreatable cases: Interdisciplinary medical care to improve quality of life, reduce pain, and suffering.
- Treatment of side effects of cancer treatment such as nausea, vomiting, hair loss, and inflammation of the skin.
- Psychological support
Top Survival Rate for Acute Lymphoblastic Leukemia Related Articles
Adult Acute Lymphoblastic Leukemia (ALL)Acute lymphoblastic leukemia (ALL) is a cancer of the blood cells that mainly affects a type of white blood cells called lymphocytes. ALL commonly affects young children, but some adults may also get this type of cancer. However, ALL in adults is rare and is one of the most challenging cancers when it comes to treatment. ALL Starts in the bone marrow, progresses rapidly, and needs immediate treatment because it can be fatal if untreated.
Adult Acute Myeloid Leukemia (AML)Acute myeloid leukemia (AML) begins in the bone marrow, but it frequently spreads to the bloodstream as well. AML usually develops from cells that would normally turn into white blood cells (other than lymphocytes) but can develop from other blood-forming cells. Leukemia may damage red blood cells, white blood cells, and platelets. AML is also called acute myelocytic leukemia, acute granulocytic leukemia, acute myelogenous leukemia, and acute nonlymphocytic leukemia.
Arzerra (ofatumumab)Arzerra (ofatumumab) Injection is a monoclonal antibody used to treat chronic lymphocytic leukemia. Common side effects of Arzerra include nausea, vomiting, diarrhea, tiredness, swelling of hands/ankles/feet, trouble sleeping, skin rash, or cold symptoms such as stuffy nose, sneezing, and sore throat. Arzerra decreases bone marrow function, which can cause anemia.
Belrapzo (bendamustine hydrochloride) InjectionBelrapzo (bendamustine hydrochloride) injection is an alkylating drug indicated for treatment of patients with chronic lymphocytic leukemia (CLL), and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. Side effects of Belrapzo include nausea, fatigue, low iron (anemia), low platelet count (thrombocytopenia), low white blood cells (neutropenia, lymphopenia, leukopenia), too much bilirubin in the blood (hyperbilirubinemia), fever, vomiting, diarrhea, constipation, weight loss, cough, headache, shortness of breath, rash, and inflammation of the mouth and lips
Blincyto (blinatumomab)Blincyto (blinatumomab) for injection is a bispecific CD19-directed CD3 T- cell engager indicated for the treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Serious side effects of Blincyto include Cytokine Release Syndrome (CRS) and neurological toxicities.
Blood Cancer TypesTypes of blood cancers include leukemia, lymphomas, multiple myelomas, and others discussed in this slideshow. Symptoms may include fever, night sweats, fatigue, and other symptoms. Blood cancer treatment depends on the type of cancer and other factors. Blood tests for cancer as well as imaging tests and needle biopsy may help diagnose the condition.
CancerCancer is a disease caused by an abnormal growth of cells, also called malignancy. It is a group of 100 different diseases, and is not contagious. Cancer can be treated through chemotherapy, a treatment of drugs that destroy cancer cells.
Guide to LeukemiaLearn about the common types and stages of leukemia, who gets it, symptoms, tests, treatments, and more. People with blood cancer are living longer than ever, and it may be curable.
How Does Leukemia Kill?Leukemia is a cancer of the white blood cells of the bone marrow. Patients with leukemia have an over-production of a particular blood cell type in the body, the white blood cells (cells that fight infection, and provide immunity).
hydroxyureaHydroxyurea is a chemotherapy drug used to treat some types of cancers including solid tumors, head and neck cancers and chronic myelocytic leukemia, a type of blood cancer. Hydroxyurea is also used to improve symptoms and manage recurrent crises in sickle cell disease. Common side effects of hydroxyurea include infections, viral infections, bacterial infections, gastrointestinal disorders, low count of neutrophil immune cells (neutropenia), low platelet levels (thrombocytopenia), fever, headache, Vitamin D deficiency, and anemia. Hydroxyurea should be used during pregnancy only in life-threatening emergencies, when no safer treatment is available. Hydroxyurea is present in breast milk; either nursing or the drug should be discontinued, taking into account the importance of the drug to the mother and potential fetal risks.
Inqovi (decitabine and cedazuridine)Inqovi (decitabine and cedazuridine) is a prescription medication used to treat adults with myelodysplastic syndromes (MDS), including chronic myelomonocytic leukemia (CMML). Serious side effects of Inqovi include low blood cell counts. It is not known if Inqovi is safe or effective in children.
LeukemiaLeukemia is a type of cancer of the blood cells in which the growth and development of the blood cells are abnormal. Strictly speaking, leukemia should refer only to cancer of the white blood cells (the leukocytes) but in practice, it can apply to malignancy of any cellular element in the blood or bone marrow, as in red cell leukemia (erythroleukemia).
Leukemia QuizWhat do you know about leukemia? Did you know there are different types? What are the symptoms? Take the Leukemia Quiz and test your knowledge and get the facts.
Leukemia: Signs, Symptoms, And ComplicationsLeukemia results when the genetic material (DNA) of a single cell in the bone marrow transforms, this is called a mutation. A mutated cell does not perform body function, but it eats away the nutrition meant for the normal cells.
What Is the Life Expectancy of a Person With Leukemia?Leukemia is a group of cancers of the blood affecting the white blood cells. White blood cells are the infection-fighting cells of the body.
In adults, leukemia is most common in people older than 55 years, with the average age of diagnosis being 66 years. It is also one of the most common cancers in children and adults younger than 20 years. The survival rate is higher for younger people.
pau d’arcoPau d’arco is used in herbal medicine to treat many conditions including respiratory problems, gastrointestinal problems, colds, cough, flu, fungal infections, fever, arthritis and rheumatism, skin conditions, leukemia, and other cancers. Common side effects of pau d’arco include nausea, vomiting, diarrhea, dizziness, and internal bleeding. Avoid use of pau d’arco during pregnancy or if breastfeeding.
Tabloid (thioguanine)Tabloid (thioguanine 40-mg) is a cancer (antineoplastic) medication used to treat certain types of leukemia. Tabloid is sometimes given with other cancer medications. Tabloid may be available in generic form. Common side effects of Tabloid include upset stomach, nausea, vomiting, diarrhea, hair loss, itching or skin rash, or darkened skin color.
Venclexta (venetoclax)Venclexta is a prescription medicine used to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) in combination with azacitidine, or decitabine, or low-dose cytarabine to treat adults with newly-diagnosed acute myeloid leukemia (AML) who are 75 years of age or older, or have other medical conditions that prevent the use of standard chemotherapy.